dipyridamole has been researched along with Arterial Occlusive Diseases in 73 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The role of adenosine in postprandial jejunal hyperemia was investigated by determining the effect of placement of predigested food into the jejunal lumen on blood flow and oxygen consumption before and during intra-arterial infusion of dipyridamole (1." | 7.68 | Role of adenosine in postprandial and reactive hyperemia in canine jejunum. ( Chou, CC; Sawmiller, DR, 1992) |
| "A review is given on the clinical studies performed with aspirin in patients with chronic vascular occlusions of the limbs and on studies in cerebral ischemia using aspirin and sulfinpyrazone." | 6.14 | Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders. ( Breddin, K, 1977) |
| "To assess the clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole (MRD) alone or with aspirin (ASA) compared with ASA (and each other where appropriate) in the prevention of occlusive vascular events in patients with a history of MI, ischaemic stroke/TIA or established peripheral arterial disease." | 4.87 | Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. ( Bagust, A; Blundell, M; Boland, A; Dickson, R; Dundar, Y; Fisher, M; Greenhalgh, J; Martin Saborido, C; Oyee, J; Proudlove, C, 2011) |
| "Platelet deposition and thrombus formation caused by angioplasty appear to be important in the development of 2 complications: acute thrombotic occlusion and restenosis." | 3.76 | Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. ( Harker, LA, 1987) |
| "In the recently published Warfarin Aspirin Recurrent Stroke Study (WARSS), a low-intensity anticoagulation regimen was used because of safety concerns." | 3.72 | Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage. ( , 2003) |
| "The role of adenosine in postprandial jejunal hyperemia was investigated by determining the effect of placement of predigested food into the jejunal lumen on blood flow and oxygen consumption before and during intra-arterial infusion of dipyridamole (1." | 3.68 | Role of adenosine in postprandial and reactive hyperemia in canine jejunum. ( Chou, CC; Sawmiller, DR, 1992) |
| "The measurement of left ventricular function by gated blood pool scanning and of myocardial perfusion by dipyridamole thallium imaging were compared in a prospective study of patients who had abdominal aortic aneurysm or aortoiliac occlusive disease to determine which measurement was the better predictor of postoperative cardiac complications." | 3.68 | Comparison of left ventricular function and myocardial perfusion for evaluating perioperative cardiac risk of abdominal aortic surgery. ( Barber, GG; Calvin, JE; Cole, CW; Davies, RA; Gulenchyn, KY; McPhail, NV; Ruddy, TD, 1990) |
| "The individual and combined predictive values of dipyridamole-thallium imaging and exercise testing were compared in a prospective study of 70 patients who had abdominal aortic aneurysms or aortoiliac occlusive disease that required surgical repair." | 3.67 | A comparison of dipyridamole-thallium imaging and exercise testing in the prediction of postoperative cardiac complications in patients requiring arterial reconstruction. ( Barber, GG; Calvin, JE; Davies, RA; McPhail, NV; Ruddy, TD, 1989) |
| "The relationship of coronary anatomy to right ventricular (RV) appearance on serial thallium-201 myocardial imaging (TI) following dipyridamole (DP)-induced coronary vasodilation was examined in 71 consecutive patients undergoing coronary angiography for the evaluation of chest pain." | 3.66 | Initial and delayed right ventricular thallium-201 rest-imaging following dipyridamole-induced coronary vasodilation: relationship to right coronary artery pathoanatomy. ( Boucher, CA; Brown, KA; Okada, RD; Pohost, G; Strauss, HW, 1982) |
| "Dipyridamole was administered in 550 PTCA procedures (455 interventions in men, mean (SD) age 59." | 2.69 | Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial. ( Heidland, UE; Heintzen, MP; Kelm, M; Klimek, WJ; Leschke, M; Michel, CJ; Schwartzkopff, B; Strauer, BE; Vester, EG, 2000) |
| "Taprostene was administered to 19 patients as a continuous intravenous infusion from 2 hours before until 8 (n = 6) or 24 (n = 6) hours after angioplasty; 7 control patients were given a combination of 330 mg aspirin and 75 mg dipyridamole." | 2.68 | [The effect of Taprostene on platelet activation and clinical course after percutaneous transluminal angioplasty]. ( Heinz, M; Söhngen, M; Theiss, W; van de Flierdt, E, 1996) |
| "Indications for surgery included vertebrobasilar insufficiency (22." | 1.30 | Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy. ( Dresler, C; Haverich, A; Wahlers, T; Wittwer, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (68.49) | 18.7374 |
| 1990's | 15 (20.55) | 18.2507 |
| 2000's | 6 (8.22) | 29.6817 |
| 2010's | 2 (2.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Schryver, EL | 1 |
| Algra, A | 1 |
| Greenhalgh, J | 1 |
| Bagust, A | 1 |
| Boland, A | 1 |
| Martin Saborido, C | 1 |
| Oyee, J | 1 |
| Blundell, M | 1 |
| Dundar, Y | 1 |
| Dickson, R | 1 |
| Proudlove, C | 1 |
| Fisher, M | 1 |
| Mondillo, S | 1 |
| Ballo, P | 1 |
| Agricola, E | 1 |
| Guerrini, F | 1 |
| Barbati, R | 1 |
| Ammaturo, T | 1 |
| Bertelli, P | 1 |
| Neri, E | 1 |
| Sassi, C | 1 |
| Dörffler-Melly, J | 1 |
| Schmidli, J | 1 |
| Mahler, F | 2 |
| Aronow, WS | 1 |
| Landolfi, R | 1 |
| Di Gennaro, L | 1 |
| Heidrich, H | 1 |
| Bergqvist, D | 1 |
| Goldman, MD | 1 |
| Simpson, D | 1 |
| Hawker, RJ | 1 |
| Norcott, HC | 1 |
| McCollum, CN | 1 |
| Bollinger, A | 3 |
| Biland, L | 1 |
| Brunner, U | 2 |
| Kappert, A | 1 |
| Krähenbühl, B | 1 |
| Monti, M | 1 |
| Nachbur, B | 1 |
| Schneider, E | 1 |
| Widmer, LK | 1 |
| Kistler, JP | 1 |
| Ropper, AH | 1 |
| Heros, RC | 1 |
| Heinrich, F | 1 |
| Rushton, FW | 1 |
| Kukora, JS | 1 |
| Green, RM | 1 |
| Roedersheimer, LR | 1 |
| DeWeese, JA | 1 |
| Loew, D | 2 |
| Hess, H | 3 |
| Hashimoto, H | 1 |
| Suzuki, K | 1 |
| Miyake, S | 1 |
| Nakashima, M | 1 |
| Cristol, R | 1 |
| Josephson, MA | 1 |
| Brown, BG | 1 |
| Hecht, HS | 1 |
| Hopkins, J | 1 |
| Pierce, CD | 1 |
| Petersen, RB | 1 |
| Brown, KA | 1 |
| Boucher, CA | 1 |
| Okada, RD | 1 |
| Strauss, HW | 1 |
| Pohost, G | 1 |
| Chilian, WM | 1 |
| Marcus, ML | 1 |
| Jacobi, E | 1 |
| Bremer, G | 1 |
| Richter, O | 1 |
| Smith, RS | 1 |
| Warren, DJ | 1 |
| Blumenthal, DS | 1 |
| Hutchins, GM | 1 |
| Jugdutt, BI | 1 |
| Becker, LC | 2 |
| Fitzgerald, GA | 1 |
| Meagher, EA | 1 |
| van den Berkmortel, FW | 1 |
| Wollersheim, H | 1 |
| Heijstraten, FM | 1 |
| Thien, T | 1 |
| Steinberg, JB | 1 |
| Kresowik, TF | 1 |
| Behrendt, DM | 1 |
| Astorri, E | 1 |
| Saccani, S | 1 |
| Beghi, C | 1 |
| Raise, G | 1 |
| Chikamori, T | 1 |
| Doi, Y | 1 |
| Yonezawa, Y | 1 |
| Yamada, M | 1 |
| Ozawa, T | 1 |
| Erickson, CA | 1 |
| Carballo, RE | 1 |
| Freischlag, JA | 1 |
| Seabrook, GR | 1 |
| Farooq, MM | 1 |
| Cambria, RA | 1 |
| Towne, JB | 1 |
| Heinz, M | 1 |
| Theiss, W | 1 |
| van de Flierdt, E | 1 |
| Söhngen, M | 1 |
| Wittwer, T | 1 |
| Wahlers, T | 1 |
| Dresler, C | 1 |
| Haverich, A | 1 |
| Klonaris, CN | 1 |
| Bastounis, EA | 1 |
| Xiromeritis, NC | 1 |
| Balas, PE | 1 |
| Heintzen, MP | 1 |
| Heidland, UE | 1 |
| Klimek, WJ | 1 |
| Leschke, M | 1 |
| Kelm, M | 1 |
| Schwartzkopff, B | 1 |
| Vester, EG | 1 |
| Michel, CJ | 1 |
| Strauer, BE | 1 |
| Vigdahl, RL | 1 |
| Ferber, RH | 1 |
| Parrish, SL | 1 |
| Breddin, K | 1 |
| Zicot, M | 1 |
| Weissbach, G | 1 |
| Ostendorf, P | 1 |
| Ziesenhenn, K | 1 |
| O'Sullivan, DJ | 1 |
| Lim, GH | 1 |
| Darveniza, P | 1 |
| Coffey, GL | 1 |
| Müller-Fassbender, H | 1 |
| Ingrisch, H | 1 |
| Mietaschk, A | 2 |
| Verstraete, M | 1 |
| Wu, KK | 1 |
| Hoak, JC | 1 |
| Genton, E | 1 |
| Gent, M | 1 |
| Hirsh, J | 1 |
| Harker, LA | 3 |
| Browder, A | 1 |
| Browder, J | 1 |
| Sawmiller, DR | 1 |
| Chou, CC | 1 |
| Pilger, E | 2 |
| Lammer, J | 1 |
| Bertuch, H | 1 |
| Stark, G | 1 |
| Decrinis, M | 1 |
| Pfeiffer, KP | 1 |
| Krejs, GJ | 1 |
| McCollum, C | 1 |
| Kenchington, G | 1 |
| Alexander, C | 1 |
| Franks, PJ | 1 |
| Greenhalgh, RM | 1 |
| Mousa, SA | 1 |
| Cooney, JM | 1 |
| Williams, SJ | 1 |
| Frauchiger, B | 1 |
| McPhail, NV | 2 |
| Ruddy, TD | 2 |
| Calvin, JE | 2 |
| Barber, GG | 2 |
| Cole, CW | 1 |
| Davies, RA | 2 |
| Gulenchyn, KY | 1 |
| Di Perri, T | 2 |
| Pasini, FL | 1 |
| Pecchi, S | 1 |
| De Franco, V | 1 |
| Damiani, P | 1 |
| Pasqui, AL | 1 |
| Capecchi, PL | 1 |
| Orrico, A | 1 |
| Materazzi, M | 1 |
| Domini, L | 1 |
| Vitoux, JF | 1 |
| Languillat, N | 1 |
| du Peloux, L | 1 |
| Lévy, M | 1 |
| Fiessinger, JN | 1 |
| Deichsel, G | 1 |
| Zeitler, E | 1 |
| Brewer, ML | 1 |
| Kinnison, ML | 1 |
| Perler, BA | 1 |
| White, RI | 1 |
| Hainaut, P | 1 |
| Lavenne, E | 1 |
| Magy, JM | 1 |
| Lebacq, EG | 1 |
| Nabeyama, S | 1 |
| Tomoike, H | 1 |
| Hisano, K | 1 |
| Shimokawa, H | 1 |
| Inoue, T | 1 |
| Yamamoto, H | 1 |
| Nakamura, M | 1 |
| Freeman, JW | 1 |
| Naide, D | 1 |
| Lima, JA | 1 |
| Melin, JA | 1 |
| Lima, S | 1 |
| Kallman, CA | 1 |
| Weisfeldt, ML | 1 |
| Weiss, JL | 1 |
| Wilding, RP | 1 |
| Flute, PT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000527] | Phase 2 | 0 participants | Interventional | 1986-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 reviews available for dipyridamole and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Secondary stroke prevention with antithrombotic drugs.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Cyclooxygenase Inhibitors; Dipyridamole; Drug | 2010 |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Delayed-Ac | 2011 |
Antiplatelet therapy in peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Humans; Peripheral Vascular Disease | 2004 |
[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
Topics: Ancrod; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiomyopathies; Dextrans; Digitalis | 1981 |
Pharmacological prevention of thrombotic occlusion in arterial reconstructive surgery.
Topics: Arachidonic Acid; Arachidonic Acids; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cyclic A | 1983 |
Therapy of ischemic cerebral vascular disease due to atherothrombosis. (2).
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Basilar Artery; Blood Platelets; | 1984 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
Antiplatelet drugs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Integrins; Platelet Aggregation | 1994 |
Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Brain Ischemia; Cell Survival; Clinical Trial | 1977 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agent | 1979 |
[Thrombosis prevention and treatment in pediatrics].
Topics: Adolescent; Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Child; Child, Preschool; Coumarins; | 1979 |
Are agents affecting platelet functions clinically useful?
Topics: Aged; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyrida | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Dipyr | 1987 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
The management of TIAs in 1986.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Dipyridamo | 1986 |
15 trials available for dipyridamole and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Noninvasive tests for risk stratification in major vascular surgery.
Topics: Aged; Aortic Aneurysm; Arterial Occlusive Diseases; Coronary Disease; Dipyridamole; Echocardiography | 2002 |
Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamol | 1983 |
Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamol | 1982 |
[Aggregation inhibitors or anticoagulants in the prevention of peripheral arterial occlusive diseases].
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Clinical Trials as Topic; Dipyr | 1982 |
Effect of nicotinic acid and dipyridamole on tissue blood flow in peripheral vascular disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Dipyridamole; Double-Blind Method; Humans; Middle Aged; Mu | 1981 |
[Thallium-201 myocardial perfusion imaging after aortocoronary bypass in patients treated with sulodexide or ASA-dipyridamole].
Topics: Arterial Occlusive Diseases; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Drug Evalua | 1993 |
[The effect of Taprostene on platelet activation and clinical course after percutaneous transluminal angioplasty].
Topics: Administration, Oral; Adult; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Cardi | 1996 |
Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arterial Occlusive Diseases; Aspirin; C | 2000 |
Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Brain Ischemia; Cell Survival; Clinical Trial | 1977 |
[Prevention of re-occlusion after recanalisation of occluded arteries by the catheter method (author's transl)].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 1978 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results.
Topics: Aged; Angioplasty, Balloon; Angioplasty, Laser; Arterial Occlusive Diseases; Aspirin; Dipyridamole; | 1991 |
PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.
Topics: Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Blood Vessel Prosthesis; Combined Modality Ther | 1991 |
Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Doubl | 1985 |
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Dipyr | 1987 |
45 other studies available for dipyridamole and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bl | 2003 |
Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.
Topics: Anticoagulants; Arterial Occlusive Diseases; Asia, Southeastern; Aspirin; Brain Ischemia; Dipyridamo | 2003 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; | 2008 |
[Therapy of peripheral arterial occlusive diseases. Round table conference].
Topics: Alprostadil; Angioplasty, Balloon; Anti-Bacterial Agents; Anticoagulants; Arterial Occlusive Disease | 1983 |
[Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Int | 1984 |
Surgical management of the occluded carotid artery.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Arteries; Carotid Artery Diseases; Cerebr | 1984 |
Effects of calcium antagonists on the electrical alternans of the ST segment and on associated mechanical alternans during acute coronary occlusion in dogs.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Disease; Dil | 1983 |
Noninvasive detection and localization of coronary stenoses in patients: comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging.
Topics: Adult; Aged; Arterial Occlusive Diseases; Coronary Disease; Dipyridamole; Electrocardiography; Exerc | 1982 |
Initial and delayed right ventricular thallium-201 rest-imaging following dipyridamole-induced coronary vasodilation: relationship to right coronary artery pathoanatomy.
Topics: Adult; Aged; Arterial Occlusive Diseases; Coronary Angiography; Coronary Disease; Coronary Vessels; | 1982 |
Phasic coronary blood flow velocity in intramural and epicardial coronary arteries.
Topics: Animals; Arterial Occlusive Diseases; Blood Flow Velocity; Cardiac Pacing, Artificial; Coronary Circ | 1982 |
Platelet adhesiveness: methodology for testing in humans.
Topics: Arterial Occlusive Diseases; Cell Survival; Densitometry; Diabetes Mellitus; Dipyridamole; Humans; I | 1981 |
Salvage of ischemic myocardium by dipyridamole in the conscious dog.
Topics: Animals; Arterial Occlusive Diseases; Coronary Disease; Coronary Vessels; Dipyridamole; Dogs; Hemody | 1981 |
[5 patients with Takayasu's disease in The Netherlands].
Topics: Adolescent; Adult; Aortography; Arterial Occlusive Diseases; Aspirin; Child; Dipyridamole; Drug Ther | 1995 |
Prophylactic myocardial revascularization based on dipyridamole-thallium scanning before peripheral vascular surgery.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cause of Death; Combined Modality Thera | 1993 |
Noninvasive evaluation of total occlusion of infarct-related coronary artery after a first myocardial infarction.
Topics: Adult; Aged; Arterial Occlusive Diseases; Coronary Vessels; Dipyridamole; Evaluation Studies as Topi | 1993 |
Using dipyridamole-thallium imaging to reduce cardiac risk in aortic reconstruction.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Aortic Aneurysm, Abdominal; Arterial Occlusive Diseases; Dipy | 1996 |
Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy.
Topics: Adult; Aged; Angiography; Anticoagulants; Arm; Arterial Occlusive Diseases; Aspirin; Blood Vessel Pr | 1998 |
The predictive value of dipyridamole-thallium scintigraphy for cardiac risk assessment before major vascular surgery.
Topics: Aged; Aortic Aneurysm, Abdominal; Arterial Occlusive Diseases; Coronary Disease; Dipyridamole; Femal | 1998 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Di | 1979 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders | 1979 |
[Case contribution to the problem of side effects in the dipyridamol test].
Topics: Arterial Occlusive Diseases; Dipyridamole; Drug Hypersensitivity | 1979 |
Multiple progressive intracranial arterial occlusions ('moyamoya' disease).
Topics: Adrenal Cortex Hormones; Adult; Antihypertensive Agents; Arterial Occlusive Diseases; Cerebral Angio | 1977 |
[Thrombocyte-aggregation inhibitors following open or semi-open endarterectomy-preliminary results of a prospective study].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Endarterectomy; Humans; Platelet Aggregation; Po | 1978 |
[Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications.
Topics: Adenosine; Adult; Aged; Angina Pectoris; Apyrase; Arterial Occlusive Diseases; Aspirin; Coronary Dis | 1976 |
Prevention of stroke.
Topics: Age Factors; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Cerebral Angiograph | 1975 |
Role of adenosine in postprandial and reactive hyperemia in canine jejunum.
Topics: Adenosine; Adenosine Deaminase; Animals; Arterial Occlusive Diseases; Blood Volume; Dipyridamole; Do | 1992 |
Relationship between regional myocardial blood flow and the distribution of 99mTc-sestamibi in the presence of total coronary artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Dipyridamole; Heart; M | 1990 |
[Conservative therapy of peripheral arterial occlusive disease].
Topics: Alprostadil; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Exercise; Humans; L | 1990 |
Comparison of left ventricular function and myocardial perfusion for evaluating perioperative cardiac risk of abdominal aortic surgery.
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Arterial Occlusive Diseases; Dipyridamole; Female; Gated Bl | 1990 |
In vivo and in vitro evidence of an adenosine-mediated mechanism of calcium entry blocker activities.
Topics: Adenosine; Arterial Occlusive Diseases; Calcium Channel Blockers; Dipyridamole; Female; Flunarizine; | 1989 |
[Role of myocardium scintigraphy with thallium dipyridamole in the evaluation of arterial disease of the legs].
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Arteriosclerosis; Dipyridamole; Female; | 1989 |
A comparison of dipyridamole-thallium imaging and exercise testing in the prediction of postoperative cardiac complications in patients requiring arterial reconstruction.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Aortic Aneurysm; Arterial Occlusive Diseases; Dipy | 1989 |
[Percutaneous transluminal recanalization of chronic stenoses and occlusions of peripheral arteries].
Topics: Angiography; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Femoral Arter | 1985 |
[Secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinp | 1987 |
Blue toe syndrome: treatment with anticoagulants and delayed percutaneous transluminal angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cyanosis; D | 1988 |
Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Blood Coagulation Factors; Dipyridamole; Female; Hand; | 1986 |
Collateral function modified by glyceryl trinitrate and dipyridamole during coronary occlusion in conscious dogs.
Topics: Animals; Arterial Occlusive Diseases; Collateral Circulation; Coronary Circulation; Coronary Disease | 1987 |
Dipyridamole.
Topics: Arterial Occlusive Diseases; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Postoperative Co | 1987 |
Drug therapy for peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Calcium Channel Blockers; Dipyridamole; Humans; Pentoxifylline; Theobro | 1986 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; D | 1985 |
[Computer-assisted in vivo study of capillary permeability].
Topics: Adolescent; Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Aspirin; Capillary Permeability; | 1985 |
Impaired thickening of nonischemic myocardium during acute regional ischemia in the dog.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Diastol | 1985 |
Antiplatelet drugs improve the patency rates after femoro-popliteal endarterectomy.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Dipyridamole; Endarterectomy; Female; Femoral | 1985 |
Letter: Dipyridamole in peripheral upper-limb ischaemia.
Topics: Administration, Oral; Aged; Arm; Arterial Occlusive Diseases; Dipyridamole; Female; Humans; Ischemia | 1974 |